Robert Michael Floyd - 16 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
4
Filing time
23 Aug 2022, 16:34:06 UTC
Previous filing
05 Jul 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Gift $0 -7,000 -9.9% $0.000000 63,930 16 Aug 2022 Direct
holding PCSA Common Stock 66,345 16 Aug 2022 by Elion Oncology, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.